Health and Wellness Products for Fatigue
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new health and wellness product designed to reduce fatigue in women experiencing menopause. Participants will use either the Fatigue Active Product 1 or a placebo to assess their effects on energy levels and related health outcomes. It suits those with at least two menopausal symptoms who are open to trying a new product without knowing if it's active or a placebo. As an unphased trial, this study allows participants to contribute to innovative research in health and wellness.
Will I have to stop taking my current medications?
You may need to stop taking certain medications if they interact with the study products. These include medications like anticoagulants, antidepressants, and others listed in the trial's exclusion criteria. It's best to discuss your current medications with the trial team to see if any changes are needed.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Earlier research provides limited specific safety information about Fatigue Active Product 1. However, past studies reported no negative side effects, suggesting the treatment might be well-tolerated. Prospective participants should know that previous participants did not report any major safety issues. Discuss any concerns with the trial team or your doctor before participating.12345
Why are researchers excited about this trial?
Researchers are excited about Fatigue Active Product 1 because it offers a fresh approach to managing fatigue. Unlike current treatments like stimulants or lifestyle changes, this product introduces a novel ingredient that targets energy regulation at a cellular level, potentially offering more sustainable relief. This innovation could translate to quicker and longer-lasting effects without the usual crash associated with other fatigue treatments.
What evidence suggests that this trial's treatments could be effective for fatigue?
Research shows that Fatigue Active Product 1, which participants in this trial may receive, might help reduce tiredness in people with menopausal symptoms. Studies have found that similar wellness products can improve fatigue by at least 30%. Users of these products often feel less tired than those taking a placebo. In this trial, some participants will receive a placebo control, which looks the same but contains no active ingredients. Although more information is needed, these early results are promising for those dealing with fatigue.12678
Who Is on the Research Team?
Susan Hewlings
Principal Investigator
Radicle Science
Are You a Good Fit for This Trial?
This trial is for women aged 35-60 living in the US, assigned female at birth, who have at least two menopausal symptoms and are willing to try a study product without knowing if it's real or placebo. Participants must not be pregnant, breastfeeding, on certain medications, or have serious health conditions like heart, liver, or kidney disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive health and wellness products or placebo for 7 weeks to assess impact on fatigue and related health outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Fatigue Active Product 1
- Fatigue Product Placebo Control
Trial Overview
The study compares an active health and wellness product designed to reduce fatigue with a placebo in women experiencing menopausal symptoms. It is randomized and double-blind—neither participants nor researchers know which product each person receives until the end.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Fatigue Active Product 1
Fatigue Product Placebo Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Radicle Science
Lead Sponsor
Citations
Energy Active Product for Fatigue · Info for Participants
This trial tests a new product, Energy Active Product, to determine its effectiveness in reducing fatigue compared to a placebo (a look-alike product with ...
The FATIGUE-PRO: a new patient-reported outcome ... - PMC
This study aimed to implement a patient-centred and evidence-based approach to develop a novel patient-reported outcome (PRO) instrument to measure fatigue ...
Radicle Energy: A Study Assessing the Impact of Health ...
This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States.
Mirikizumab Sustained Impact on Fatigue in Patients with ...
Mirikizumab treatment significantly improved fatigue in patients with moderately to severely active CD, which was sustained to W104.
Impact of mirikizumab treatment on fatigue in patients with ...
Conclusions: Mirikizumab-treated patients with CD achieved higher rates of clinically meaningful improvement in fatigue vs placebo at Weeks 12 ...
6.
ctv.veeva.com
ctv.veeva.com/study/radicle-energy-24-a-study-of-health-and-wellness-products-on-fatigue-and-related-health-outcomesRadicle Energy 24: A Study of Health and Wellness Products ...
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on fatigue and related health outcomes.
Radicle Health1: A Study of Health and Wellness ...
This is a randomized, blinded, placebo-controlled study conducted with adult participants, age 21 and older and residing in the United States.
Efficacy of rintatolimod in the treatment of chronic fatigue ...
Rintatolimod has achieved statistically significant improvements in primary endpoints in Phase II and Phase III double-blind, randomized, placebo-controlled ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.